From the Journals
Healthy Lifestyle Lowers Cardiometabolic Risk in Hypertension
-
By
-
March 20, 2026
-
5 min
By
March 20, 2026
A 2026 expert perspective highlights system-level gaps in care delivery
by Kerri Miller
March 20, 2026
First and only FDA-approved therapy showed an 18.4% placebo-adjusted BMI reduction at 52 weeks
by Kerri Miller
March 20, 2026
Semaglutide 7.2 mg achieved 20.7% mean weight loss in STEP UP trials.
March 19, 2026